Timo Soeterik

176 CHAPTER 10 REFERENCES 1. Soeterik TFW, van Melick HHE, Dijksman LM, Biesma DH, Witjes JA, van Basten JPA. Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients. Eur Urol Oncol . 2018;1:231-237. 2. Mottet N, van den Bergh RCN, Briers E, et al. EAU - ESTRO - ESUR - SIOG Guidelines on Prostate Cancer 20202; presented at the EAU Annual Congress Amsterdam 2020. Arnhem, The Netherlands: European Association of Urology Guidelines Office. 3. Soeterik TFW, van Melick HHE, Dijksman LM, Biesma DH, Witjes JA, van Basten JPA. Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients. Eur Urol Oncol . 2019;2:483-489. 4. Lam TBL, MacLennan S, Willemse PPM, et al. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). Eur Urol . 2019;76:790-813. 5. Freifeld Y, Diaz de Leon A, Xi Y, et al. Diagnostic Performance of Prospectively Assigned Likert Scale Scores to Determine Extraprostatic Extension and Seminal Vesicle Invasion With Multiparametric MRI of the Prostate. AJR Am J Roentgenol. 2019;212:576-581. 6. Ball MW, Partin AW, Epstein JI. Extent of extraprostatic extension independently influences biochemical recurrence- free survival: Evidence for further PT3 subclassification. Urology . 2015;85(1):161-164. 7. Jeong BC, Chalfin HJ, Lee SB, et al. The relationship between the extent of extraprostatic extension and survival following radical prostatectomy. Eur Urol . 2015;67:342-346. 8. Onay A, Ertas G, Vural M, Colak E, Esen T, Bakir B. The role of T2-weighted images in assessing the grade of extraprostatic extension of the prostate carcinoma. Abdom Radiol . 2020;45:3293-3300. 9. Coelho RF, Chauhan S, Orvieto MA, Palmer KJ, Rocco B, Patel VR. Predictive Factors for Positive Surgical Margins and Their Locations After Robot-Assisted Laparoscopic Radical Prostatectomy. Eur Urol . 2010;57:1022-1029. 10. Lavery HJ, Nabizada-Pace F, Carlucci JR, Brajtbord JS, Samadi DB. Nerve sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious. Urol Oncol Semin Orig Investig . 2012;30:26-32. 11. Sighinolfi MC, Sandri M, Torricelli P, et al. External validation of a novel side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer: preliminary outcomes on a series diagnosed with multiparametric magnetic resonance im. BJU Int . 2019;124:192-194. 12. Santeon mpmri-based nomogram to predict side-specific extraprostatic extension. ht t ps://www. ev idenc io. com/mode l s/ show/2142. Published 2020. 13. Wibmer A, Vargas HA, Donahue TF, et al. Diagnosis of extracapsular extension of prostate cancer on prostate MRI: Impact of second-opinion readings by subspecialized genitourinary oncologic radiologists. Am J Roentgenol . 2015;205:73-78. 14. Wang AZ, Oonnor LP, Yerram NK, et al. PIRADS Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer inMen on Active Surveillance. J Urol . 2020;204:1229-1235. 15. Luiting HB, van Leeuwen PJ, Busstra MB, et al. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature. BJU Int . 2020;125:206-214. 16. Alberts AR, Roobol MJ, Drost FJH, et al. Risk- stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow- up biopsy procedures in men on active surveillance for low-risk prostate cancer. BJU Int . 2017;120:511-519.